๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura

โœ Scribed by Elham Shahgholi; Parvaneh Vosough; Kambiz Sotoudeh; Khadijeh Arjomandi; Shahla Ansari; Soraya Salehi; Mohammad Faranoush; Mohammad Ali Ehsani


Book ID
107598390
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
218 KB
Volume
75
Category
Article
ISSN
0019-5456

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The cost of treating immune thrombocytop
โœ Sandler, S. Gerald; Novak, Sharon C.; Roland, Barbara ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 18 KB ๐Ÿ‘ 2 views

Multiple factors, including efficacy, toxicity and cost, may influence the decision to treat immune thrombocytopenic purpura (ITP) with intravenous immune globulin (IVIG) or intravenous Rho (D) immune globulin (IV RhIG). We conducted a survey of 50 hospitals in 31 states to determine the costs for t

Plasmapheresis and intravenous immune gl
โœ Deborah J. Novak; Lisa N. Tyler; Ramakrishna L. Reddy; Michael J. Barsoom ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB

## Abstract The alloimmunized pregnancy can result in fetal and newborn mortality due to fetal anemia. Control of fetal anemia has not been possible until recently, and management consists of following the degree of fetal anemia during gestation until intrauterine transfusion is feasible to support